Al Razi profit rises 5% to SAR 606,000 in H1 2023

31/08/2023 Argaam Exclusive

View other reports

Al Razi Medical Co. reported a 5% increase in H1 2023 net profit to SAR 606,000, from SAR 580,000 in the year-earlier period, driven by better sales.

Financials (M)

Item	6m 2022	6m 2023	Change‬
Revenues	24.07	30.54	26.9 %
Gross Income	7.10	9.15	29.0 %
Operating Income	0.77	1.00	29.6 %
Net Income	0.58	0.61	4.6 %
Average Shares	1.52	1.52	-
EPS (Riyals)	0.38	0.40	4.6 %

Current Half Annual Comparison (M)

Compared With The

Item	H1 2022	H1 2023	Change‬
Revenues	24.07	30.54	26.9 %
Gross Income	7.10	9.15	29.0 %
Operating Income	0.77	1.00	29.6 %
Net Income	0.58	0.61	4.6 %
Average Shares	1.52	1.52	-
EPS (Riyals)	0.38	0.40	4.6 %

Item	H2 2022	H1 2023	Change‬
Revenues	28.32	30.54	7.9 %
Gross Income	9.01	9.15	1.6 %
Operating Income	1.82	1.00	(45.2 %)
Net Income	1.43	0.61	(57.7 %)
Average Shares	1.52	1.52	-
EPS (Riyals)	0.94	0.40	(57.7 %)

Total shareholders’ equity, no minority interest, rose to SAR 23.04 million as of June 30, 2023, from SAR 22.93 million a year earlier.

Historical Data
Period	Revenue (SAR mln)	Net Profit (SAR mln)	EPS (SAR)
H1 2022	24.07	0.58	0.38
H2 2022	28.32	1.43	0.94
H1 2023	30.54	0.61	0.40

View More Financial Results

Kindly, you can view the full report by subscribing to the

The report contains the details of the financial statements, The most important financial indicators, Historical information, Charts, and Forecasts of experts.

Twitter

Facebook

Linked in

Comments {{getCommentCount()}}

Be the first to comment

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

Sorry: the validity period has ended to comment on this news

Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.

×